Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Protection certificate |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 12 2018 000 052.3 |
| Use | VZ | Medicinal products |
95 | Product name | TIEZ | Niraparibtosylat, einschließlich Niraparibtosylatmonohydrat |
54 | Title of basic patent | TIGZ | PHARMAZEUTISCH AKZEPTABLE SALZE VON 2-{4-?(3S)-PIPERIDIN-3- [L]PHENYL} -2H-INDAZOL-7-CARBOXAMID |
51 | IPC main class | ICM (ICMV) | C07D 401/10 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/454 (2006.01), A61P 35/00 (2006.01) |
94 | Start of term of protection | LB | Jan 9, 2029 |
94 | End of term of protection | LE | Nov 20, 2032 |
22 | DE application date | DAT | May 15, 2018 |
| Date of publication of application for a certificate | OT | Aug 2, 2018 |
| Date of publication of grant of certificate | PET | Feb 20, 2020 |
71/73 | Applicant/owner | INH | Merck Sharp & Dohme LLC, 126 East Lincoln Avenue, 07065 Rahway, NJ, US |
74 | Representative | VTR | Abitz & Partner Patentanwälte mbB, 81925 München, DE |
| Address for service | | Abitz & Partner Patentanwälte mbB, 81628 München, DE |
| Due date | FT FG | Jan 31, 2029 Annual fee for the 21st year
Patent fees |
| Patent division in charge | | 44 |
68 | DE file number of basic patent | GAKZ | 60 2009 032 466.7 |
68 | EP file number of basic patent | GEAKZ | 09 70 0579.7 |
43 | Date of first publication | EVT | Aug 2, 2018 |
92 92 92
| Domestic authorisation | GIS GIN GIT
| Europäische Kommission EU/1/17/1235 2017-11-16
|
93 93 93 93
| EU authorisation | GES GEC GEN GET
| Europäische Kommission EU EU/1/17/1235 2017-11-16
|
| Date of the first transfer into DPMAregister | EREGT | Aug 2, 2018 |
| Date of the (most recent) update in DPMAregister | REGT | Jul 20, 2024 (Show all update days)(Hide all update days)- Jul 20, 2024
- St.36: changed (technical change)
- Nov 25, 2023; Nov 8, 2022; Jan 26, 2022; Feb 23, 2021; Jan 26, 2021; Feb 20, 2020; Jan 17, 2020; Nov 14, 2019; Jul 16, 2019
- Historical data not available for this/these date(s)
- Aug 2, 2018
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 4)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jan 25, 2021 |
71/73 | Applicant/owner | INH | Merck Sharp & Dohme Corp., 07065 Rahway, N.J., US |
71/73 | Previous applicant/owner | INHF | Merck Sharp & Dohme Corp., 07065 Rahway, N.J., US, Merck Sharp & Dohme Ltd., EN11 9BU Hoddesdon, Hertfordshire, GB |
| Date of update of the procedure | REGT | Feb 23, 2021 |